0 items

in your cart
$0.00

  • Search for Medications
  • Viewcart | Checkout
  • Manage Account
  •  
  • Click-to-Call  

Prescription Drug Search

Strengths available for Nilotinib :

Nilotinib 150mg
Nilotinib 200mg

Search for a drug:

 

Browse Alphabetically:

A · B · C · D · E · F · G · H · I · J · K · L · M · N
O · P · Q · R · S · T · U · V · W · X · Y · Z · #

Information about GlobalPharmacyMeds.to

SSL Secured Website Certified Global Pharmacy Network Hacker Proof: Safe Shopping Experience 5th Anniversary 2002-2007

List of countries where we can ship Nilotinib:

  • Aruba
  • Australia
  • Bahrain
  • Bangladesh
  • Barbados
  • Bosnia and Herzegovina
  • Brazil
  • Chile
  • Colombia
  • Costa Rica
  • Croatia
  • Cuba
  • France
  • Grenada
  • Guadeloupe
  • Hungary
  • India
  • Indonesia
  • Ireland
  • Korea, South
  • Latvia
  • Lebanon
  • Lithuania
  • Luxembourg
  • Malta
  • Moldova, Republic of
  • Monaco
  • Paraguay
  • Peru
  • Qatar
  • Russian Federation
  • Saint Lucia
  • Seychelles
  • Singapore
  • Slovakia
  • Tonga
  • Tunisia
  • United Kingdom, UK
  • United States, US
  • Yemen
View All Countries

Latest news releases on Nilotinib:

Nilotinib - Wikipedia

Nilotinib (AMN107, trade name Tasigna), in the form of the hydrochloride monohydrate salt, is a small-molecule tyrosine kinase inhibitor approved for the treatment of ...

Nilotinib | C28H22F3N7O - PubChem - The PubChem Project

Nilotinib is an orally bioavailable aminopyrimidine-derivative Bcr-Abl tyrosine kinase inhibitor with antineoplastic activity. Designed to overcome imatinib ...

Pub MED - National Center for Biotechnology Information

Moved Permanently. The document has moved here.

Pubmed/Medline (NLM) - National Center for Biotechnology ...

Moved Permanently. The document has moved here.

DailyMed - TASIGNA- nilotinib capsule

Myelosuppression: Associated with neutropenia, thrombocytopenia and anemia. CBC should be done every 2 weeks for the first 2 months, then monthly.

Clinical Trials - National Institute on Aging | The Leader ...

Sign up to receive updates and resources delivered to your inbox. Footer Menu. Contact Us; Policies & Notices; FOIA; National Institutes of Health

Nilotinib first-line therapy in patients with Philadelphia ...

Nilotinib first-line therapy in patients with Philadelphia chromosome-negative/BCR-ABL-positive chronic myeloid leukemia in chronic phase: ENEST1st sub-analysis

Impact of age on efficacy and toxicity of nilotinib in ...

Methods. ENEST1st is an open-label, multicenter, single-arm, prospective study of nilotinib 300 mg twice daily in patients with newly diagnosed CML in chronic phase.

Customer Service
1-866-799-3435 (Use ref# 10786) | Contact Form
Copyright © 2017 GlobalPharmacyMeds.to All rights reserved. Disclaimer | Privacy Policy
Accepted Credit Cards and Payment: VISA, MASTERCARD and eCHECK